Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma

BACKGROUND: KRAS-mutant lung adenocarcinomas (LUADs) are heterogeneous and frequently occur in smokers. The heterogeneity of KRAS-mutant LUAD has been an obstacle for the drug discovery. METHODS: We integrated multiplatform datatypes and identified two corresponding subtypes in the patients and cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ke, Guo, Jintao, Liu, Kuai, Fan, Peiyang, Zeng, Yuanyuan, Xu, Chaoqun, Zhong, Jiaxin, Li, Qiyuan, Zhou, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197714/
https://www.ncbi.nlm.nih.gov/pubmed/30268834
http://dx.doi.org/10.1016/j.ebiom.2018.09.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197714/
https://www.ncbi.nlm.nih.gov/pubmed/30268834
http://dx.doi.org/10.1016/j.ebiom.2018.09.034

Ejemplares similares